Neurotoxicity Research

, Volume 5, Issue 1–2, pp 119–137 | Cite as

Neurotrophic factors for the investigation and treatment of movement disorders

  • Justo Garcia De Yébenes
  • Marina Sánchez
  • Maria Angeles Mena


Neurotrophic factors (NFs) are proteins that enhance neuronal survival, differentiation, neurotransmitter function and resistance to neurotoxins and lesions. For these reasons the NFs are considered as a new potential therapeutic tool for the treatment of neurodegenerative disorders, a group of diseases that produce the most important cause for disability in the Western world. Some NFs prevent or even reverse the behavioral, biochemical, pharmacological and histological abnormalities observed in severalin vitro andin vivo models of neurodegenerative disorders, namely Parkinson's disease. Several NFs have been investigated in primate models of neurological disorders and some of them have been used for patients with these diseases. The results so far obtained in humans have been disappointing for several reasons, including technical problems for delivery, unbearable side effects or lack of efficacy.

Future approaches for the use of NFs in humans should include the following: (1) Investigation of the putative compounds in animal models more related to the pathophysiology of each disease, such as in genetic models of neurodegenerative diseases; (2) New methods of delivery including genetic engineering by viral vectors and administration through implantable devices; (3) More precise methods of continuous response evaluation, including the novel neuroimaging techniques; (4) Investigation of the effects of behavioral stimulation and conventional pharmacotherapy on the metabolism of NFs.


FGF GDNF IGF Neurotrophins TGF Growth factors Neurodegeneration Neuroprotection Parkinson's disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adamo M, MK Raizada, and D LeRoith (1989) Insulin and insulin-like growth factor receptors in the nervous system.Mol. Neurobiol. 3, 71–100.PubMedCrossRefGoogle Scholar
  2. Adamson ED, MJ Deller and JB Warshaw (1981) Functional EGF receptors are present on mouse embryo tissues.Nature 291, 656–659.PubMedCrossRefGoogle Scholar
  3. Alexi T, JL Venero and F Hefti (1997) Protective effects of neurotrophin-4/5 and transforming growth factor- alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.Neuroscience 78, 73–86.PubMedCrossRefGoogle Scholar
  4. Altar CA, CB Boylan, C Jackson, S Hershenson, J Milleret al. (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.Proc. Natl. Acad. Sci. USA 89, 11347–11351.PubMedCrossRefGoogle Scholar
  5. Araujo DM and DC Hilt DC (1997) Glial cell line-derived neurotrophic factor aattenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.Neuroscience 81, 1099–1110.PubMedCrossRefGoogle Scholar
  6. Araujo DM, PA Lapchak, B Collier, JG Chabot and R Quirion (1989) Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system.Brain Res. 484, 130–138.PubMedCrossRefGoogle Scholar
  7. Araujo DM, JG Chabot and R Quirion (1990) Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain.Int. Rev. Neurobiol. 32, 141–174.PubMedCrossRefGoogle Scholar
  8. Baloh RH, A Gorodinsky, JP Golden, MG Tansey, CL Kecket al. (1998a) GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor family.Proc. Natl. Acad. Sci. USA 95, 5801–5806.PubMedCrossRefGoogle Scholar
  9. Baloh RH, MG Tansey, PA Lampe, TJ Fahrner, H Enomotoet al. (1998b) Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex.Neuron 21, 1291–1302.PubMedCrossRefGoogle Scholar
  10. Barde YA, D Edgar and H Thoenen (1982) Purification of a new neurotrophic factor from mammalian brain.EMBO J. 1, 549–553.PubMedGoogle Scholar
  11. Baskin DG, DP Figlewicz, SC Woods, D Porte Jr and DM Dorsa (1987) Insulin in the brain.Ann. Rev. Physiol. 49, 335–347.CrossRefGoogle Scholar
  12. Baskin DG, BJ Wilcox, DP Figlewicz and DM Dorsa (1988) Insulin and insulin-like growth factors in the CNS.Trends Neurosci. 11, 107–111.PubMedCrossRefGoogle Scholar
  13. Beck KD (1994) Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons.Prog. Neurobiol. 44, 497–516.PubMedCrossRefGoogle Scholar
  14. Beck KD, J Valverde, T Alexi, K Poulsen, B Moffatet al. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy- induced degeneration in the adult brain.Nature 373, 339–341.PubMedCrossRefGoogle Scholar
  15. Birch NP, DL Christie and AG Renwick (1984) Immunoreactive insulin from mouse brain cells in culture and whole rat brain.Biochem. J. 218, 19–27.PubMedGoogle Scholar
  16. Blottner D, R Westermann, C Grothe, P Bohlen and K Unsicker (1989) Basic fibroblast growth factor in the adrenal gland: possible trophic role for preganglionic neuronsin vivo.Eur. J. Neurosci. 1, 471–478.PubMedCrossRefGoogle Scholar
  17. Blum M and CS Weickert (1995) GDNF mRNA expression in normal postnatal development, aging, and in Weaver mutant mice.Neurobiol. Aging 16, 925–929.PubMedCrossRefGoogle Scholar
  18. Bohlen P, F Esch, A Baird, KL Jones and D Gospodarowicz (1985) Human brain fibroblast growth factor. Isolation and partial chemical characterization.FEBS Lett. 185, 177–181.PubMedCrossRefGoogle Scholar
  19. Boonstra J, PT van der Saag, WH Moolenaar and SW de Laat (1981) Rapid effects of nerve growth factor on the Na+, K+-pump in rat pheochromocytoma cells.Exp. Cell Res. 131, 452–455.PubMedCrossRefGoogle Scholar
  20. Bottenstein JE (1981) Proliferation of glioma cells in serum-free defined medium.Cancer Treat. Rep. 65, 67–70.PubMedGoogle Scholar
  21. Bowenkamp KE, AF Hoffman, GA Gerhardt, MA Henry, PT Biddleet al. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.J. Comp. Neurol. 355, 479–489.PubMedCrossRefGoogle Scholar
  22. Buj-Bello A, J Adu, LG Pinon, A Horton, J Thompson et al. (1997) Neurturin responsiveness requries a GPI-linked receptor and the Ret receptor tyrosine kinase.Nature 387, 721–724.PubMedCrossRefGoogle Scholar
  23. Carvey PM, SO McGuire and ZD Ling (2001) Neuroprotective effects of D3 dopamine receptor agonists.Parkinsonism Rrelat. Disorders 3, 213–223.CrossRefGoogle Scholar
  24. Casarejos MJ (1995) Factores de diferenciación para neuronas dopaminérgicas. Tesis doctoral (Universidad Autonoma de Madrid, Spain).Google Scholar
  25. Chauhan NB, GJ Siegel and JM Lee (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain.J. Chem. Neuroanat. 4, 277–288.CrossRefGoogle Scholar
  26. Chen XL, FJ Roisen and M Gupta (1996) The effect of priorin vitro exposure of donor cells to trophic factors in neurotransplantation.Exp. Neurol. 138, 64–72.PubMedCrossRefGoogle Scholar
  27. Chun HS, JJ Son and JH Son (2000) Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease.Neuroreport 3, 511–514.Google Scholar
  28. Clarke DW, L Mudd, FT Boyd Jr, M Fields and MK Raizada (1986) Insulin is released from rat brain neuronal cells in culture.J. Neurochem. 47, 831–836.PubMedGoogle Scholar
  29. Clarkson ED, WM Zawada and CR Freed (1997) GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neuronsin vitro.Cell Tissue Res. 2, 207–210.CrossRefGoogle Scholar
  30. Claude P, IM Parada, KA Gordon, PA D'Amore and JA Wagner (1988) Acidic fibroblast growth factor stimulates adrenal chromaffin cells to proliferate and to extend neurites, but is not a long-term survival factor.Neuron 1, 783–790.PubMedCrossRefGoogle Scholar
  31. Cohen S (1962) Isolation of a mouse submaxilary gland protein accelerating incisor eruption and eyelid opening in the newborn animal.J. Biol. Chem. 237, 1555–562.PubMedGoogle Scholar
  32. Cohen S and G Carpenter (1975) Human epidermal growth factor: isolation and chemical and biological properties.Proc. Natl. Acad. Sci. USA 72, 1317–1321.PubMedCrossRefGoogle Scholar
  33. Connor B and M Dragunow (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain.Brain Res. Brain Res. Rev. 1, 1–39.CrossRefGoogle Scholar
  34. Cooper MJ, GM Hutchins, PS Cohen, LJ Helman and MA Israel (1991) Neuroblastoma cell lines mimic chromaffin neuroblast maturation.Prog. Clin. Biol. Res. 366, 343–350.PubMedGoogle Scholar
  35. Cordon-Cardo C, P Tapley, SQ Jing, V Nanduri, E O'Rourkeet al. (1991) The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.Cell 66, 173–183.PubMedCrossRefGoogle Scholar
  36. Cowan WM (1973) Neuronal death as a regulative mechanism in the control of cell number in the nervous system, In: M Rockstein, Ed.,Development and Aging in the Nervous System (Academic Press, New York), pp 19–41.Google Scholar
  37. Date I, MF Notter, SY Felten and DL Felten (1990) MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by sterotaxic injection of acidic fibroblast growth factor (aFGF).Brain Res. 526, 156–160.PubMedCrossRefGoogle Scholar
  38. De Felipe J and EG Jones (1991)Degeneration and Regeneration of the Nervous System (Oxford University Press, Oxford).Google Scholar
  39. De Yébenes JG, R Sánchez-Pernaute, JM Garridoet al. (1996) Effects of neurotrophic factors in MPTP lesioned monkeys.Neurology 46, A443.Google Scholar
  40. De Yébenes JG, R Sánchez-Pernaute, JM Garrido, A Rábano, J Albisua, A Rojoet al. (1998) Long-term intracerebral infusion of fibroblast growth factors restores motility and enhances F-DOPA uptake in parkinsonian monkeys.Parkinsonism Relat. Ddisorders 4, 147–158.CrossRefGoogle Scholar
  41. Diamond L, TG O'Brien and WM Baird (1980) Tumor promoters and the mechanism of tumor promotion.Adv. Cancer Res. 32, 1–74.PubMedCrossRefGoogle Scholar
  42. Ehringer H and O Hornykiewicz (1960) Verteilung von Noradrenaline und Dopamine (3-hydroxytyramine) in Gehirn des Menschen und ihr bei Erkrakungen des extrapiramidalen Systems.Klin. Wochenschr. 43, 711–715.Google Scholar
  43. Emeric DF, SR Winn, PM Hantraye, M Peschanski, EY Chenet al. (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.Nature 386, 395–399.CrossRefGoogle Scholar
  44. Engele J and MC Bohn (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia.J. Neurosci. 11, 3070–3078.PubMedGoogle Scholar
  45. Enokido Y, F de Sauvage, JA Hongo, N Ninkina, A Rosenthalet al. (1998) GFR alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin.Curr. Biol. 8, 1019–1022.PubMedCrossRefGoogle Scholar
  46. Espejo EF, RJ Montoro, JA Armengol and J Lopez-Barneo (1998) Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.Neuron 2, 197–206.CrossRefGoogle Scholar
  47. Fernandez AM, AG de la Vega and I Torres-Aleman (1998) Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia.Proc. Natl. Acad. Sci. USA 95, 1253–1258.PubMedCrossRefGoogle Scholar
  48. Ferrari G, MC Minozzi, G Toffano, A Leon and SD Skaper (1989) Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture.Dev. Biol. 133, 140–147.PubMedCrossRefGoogle Scholar
  49. Fisher LJ, HA Jinnah, LC Kale, GA Higgins and FH Gage (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa.Neuron 6, 371–380.PubMedCrossRefGoogle Scholar
  50. Fontan A, A Rojo, R Sanchez-Pernaute, I Hernandez, I Lopezet al. (2002) Effects of FGF and GDNF on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates.Parkinsonism Relat. Disorders (in press).Google Scholar
  51. Frim DM, TA Uhler, WR Galpern, MF Beal, XO Breakefieldet al. (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.Proc. Natl. Acad. Sci. USA 91, 5104–4108.PubMedCrossRefGoogle Scholar
  52. Fumagalli F, R Santero, M Gennarelli, G Racagni and M Andrea Riva (2001) Decreased hippocampal BDNF expression after acute systemic injection of quinpirole.Neuropharmacology 7, 954–957.CrossRefGoogle Scholar
  53. Gage FH, JA Wolff, MB Rosenberg, L Xu, JK Yeeet al. (1987) Grafting genetically modified cells to the brain: possibilities for the future.Neuroscience 23, 795–807.PubMedCrossRefGoogle Scholar
  54. Gash DM, MF Notter, SH Okawara, AL Kraus and RJ Joynt (1986) Amitotic neuroblastoma cells used for neural implants in monkeys.Science 233, 1420–1422.PubMedCrossRefGoogle Scholar
  55. Gash DM, Z Zhang, A Ovadia, WA Cass, A Yiet al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF.Nature 380, 252–255.PubMedCrossRefGoogle Scholar
  56. Glowacka D and JA Wagner (1990) Role of the cAMP-dependent protein kinase and protein kinase C in regulating the morphological differentiation of PC12 cells.J. Neurosci. Res. 25, 453–462.PubMedCrossRefGoogle Scholar
  57. Granholm AC, M Reyland, D Albeck, L Sanders, G Gerhardtet al. (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.J. Neurosci. 9, 3182–3190.Google Scholar
  58. Greene LA and JC McGuire (1978) Induction of ornithine decarboxylase by nerve growth factor dissociated from effects on survival and neurite outgrowth.Nature 276, 191–194.PubMedCrossRefGoogle Scholar
  59. Greene LA and G Rein (1977) Synthesis, storage and release of acetylcholine by a noradrenergic pheochromocytoma cell line.Nature 268, 349–351.PubMedCrossRefGoogle Scholar
  60. Greene LA, DE Burstein and MM Black (1982) The role of transcription-dependent priming in nerve growth factor promoted neurite outgrowth.Dev. Biol. 91, 305–316.PubMedCrossRefGoogle Scholar
  61. Grunblatt E, S Mandel, G Maor and MB Youdim (2001) Gene expression analysis inN-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.J. Neurochem. 78, 1–12.PubMedCrossRefGoogle Scholar
  62. Gunning PW, PC Letourneau, GE Landreth and EM Shooter (1981) The action of nerve growth factor and dibutyryl adenosine cyclic 3′:5′-monophosphate on rat pheochromocytoma reveals distinct stages in the mechanisms underlying neurite outgrowth.J. Neurosci. 1, 1085–1095.PubMedGoogle Scholar
  63. Gupta M, MF Notter, S Felten and DM Gash (1985) Differentiation characteristics of human neuroblastoma cells in the presence of growth modulators and and antimitotic drugs.Brain Res. 351, 21–29.PubMedGoogle Scholar
  64. Guroff G (1993) Nerve growth factor as a neurotrophic agent.Ann. NY Acad. Sci. 692, 51–59.PubMedCrossRefGoogle Scholar
  65. Hagg T and S Varon (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neuronsin vivo.Proc. Natl. Acad. Sci. USA 90, 6315–6319.PubMedCrossRefGoogle Scholar
  66. Hadjiconstantinou M, JG Fitkin, A Dalia and NH Neff (1991) Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.J. Neurochem. 57, 479–482.PubMedCrossRefGoogle Scholar
  67. Hamburger V (1934) The effects of wing bud extirpation on the development of the central nervous system in chick embryos.J. Exp. Zool. 68, 449–494.CrossRefGoogle Scholar
  68. Hamburger V and RN Openheim (1982) Naturally ocurring neuronal death in vertebrates.Neurosci. Comment 1, 39–55.Google Scholar
  69. Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections.J. Neurosci. 6, 2155–2162.PubMedGoogle Scholar
  70. Hefti F, J Hartikka and B Knusel (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases.Neurobiol. Aging 10, 515–533.PubMedCrossRefGoogle Scholar
  71. Hiramatsu M, M Kashimata, A Sato, M Murayama and N Minami (1988) Influence of age on epidermal growth factor receptor level in the rat brain.Experientia 44, 23–25.PubMedCrossRefGoogle Scholar
  72. Hofer MM and YA Barde (1988) Brain-derived neurotrophic factor prevents neuronal deathin vivo.Nature 331, 261–262.PubMedCrossRefGoogle Scholar
  73. Hofer MM, SR Pagliusi, A Hohn, J Leibrock and YA Barde (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain.EMBO J. 9, 2459–2464.PubMedGoogle Scholar
  74. Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J,et al. (1994) Glial cell line-derived neurotrophic factor reverses toxininduced injury to midbrain dopaminergic neurons in vivo.Neurosci. Lett. 182, 107–111.PubMedCrossRefGoogle Scholar
  75. Hohn A, J Leibrock, K Bailey and YA Barde (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.Nature 344, 339–341.PubMedCrossRefGoogle Scholar
  76. Honegger AM, RM Kris, A Ullrich and J Schlessinger (1989) Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular crossphosphorylation.Proc. Natl. Acad. Sci. USA 86, 925–929.PubMedCrossRefGoogle Scholar
  77. Hou JG, LF Lin and C Mytilineou (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurotrophicin vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.J. Neurochem. 66, 74–82.PubMedCrossRefGoogle Scholar
  78. Howells DW, MJ Porritt, JY Wong, PE Batchelor, R Kalninset al. (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.Exp. Neurol. 166, 127–135.PubMedCrossRefGoogle Scholar
  79. Hudson J, AC Granholm, GA, Gerhardt, MA Henry, A Hoffmanet al. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuitsin vivo.Brain Res. Bull. 36, 425–432.PubMedCrossRefGoogle Scholar
  80. Hyman C, M Hofer, YA Barde, M Juhasz, GD Yancopouloset al. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.Nature 350, 230–232.PubMedCrossRefGoogle Scholar
  81. Jing S, D Wen, Y Yu, PL Holst, Y Luoet al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.Cell 85, 1113–1124.PubMedCrossRefGoogle Scholar
  82. Kaplan DR, BL Hempstead, D Martin-Zanca, MV Chao and LF Parada (1991) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.Science 252, 554–558.PubMedCrossRefGoogle Scholar
  83. Klein R, SQ Jing, V Nanduri, E O'Rourke and M Barbacid (1991a) The trk proto-oncogene encodes a receptor for nerve growth factor.Cell 65, 189–97.PubMedCrossRefGoogle Scholar
  84. Klein R, V Nanduri, SA Jing, F Lamballe, P Tapleyet al. (1991b) The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3.Cell 66, 395–403.PubMedCrossRefGoogle Scholar
  85. Klein RD, D Sherman, WH Ho, D Stone, GL Bennettet al. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor.Nature 387, 717–721.PubMedCrossRefGoogle Scholar
  86. Knusel B, PP Michel, JS Schwaber and F Hefti (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic developmentin vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II.J. Neurosci. 10, 558–570.PubMedGoogle Scholar
  87. Knusel B, JW Winslow, A Rosenthal, LE Burton, DP Seidet al. (1991) Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.Proc. Natl. Acad. Sci. USA,88, 961–965.PubMedCrossRefGoogle Scholar
  88. Kohl NE, N Kanda, RR Schreck, G Bruns, SA Lattet al. (1983) Transposition and amplification of oncogene-related sequences in human neuroblastomas.Cell 35, 359–367.PubMedCrossRefGoogle Scholar
  89. Kontkanen O and E Castren (1999) Trophic effects of selegiline on cultured dopaminergic neurons.Brain Res. 1–2, 190–192.CrossRefGoogle Scholar
  90. Kordower JH, EY Chen, C Winkler, R Fricker, V Charleset al. (1997) Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease.J. Comp. Neurol. 387, 96–113.PubMedCrossRefGoogle Scholar
  91. Kordower JH, S Palfi, EY Chen, SY MA, T Senderaet al. (1999) Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.Ann. Neurol. 46, 419–424.PubMedCrossRefGoogle Scholar
  92. Kordower JH, ME Emborg, J Bloch, SY Ma, Y Chuet al. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.Science 290, 767–773.PubMedCrossRefGoogle Scholar
  93. Kotzbauer PT, PA Lampe, RO Heuckeroth, JP Golden, DJ, Creedonet al. (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor.Nature 384, 467–470.PubMedCrossRefGoogle Scholar
  94. Lamballe F, R Klein and M Barbacid (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3.Cell 66, 967–979.PubMedCrossRefGoogle Scholar
  95. Lapchak PA, PJ Miller, S Jiao, DM Araujo, D Hilt and F Collins (1996) Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.Neurodegeneration 5, 197–205.PubMedCrossRefGoogle Scholar
  96. Lendahl U and RD McKay (1990) The use of cell lines in neurobiology.Trends Neurosci. 13, 132–137.PubMedCrossRefGoogle Scholar
  97. Lesniak MA, JM Hill, W Kiess, M Rojeski, CB Pert and J Roth (1988) Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin.Endocrinology 123, 2089–2099.PubMedCrossRefGoogle Scholar
  98. Levi-Montalcini R (1952) Effects of mouse tumor transplantation on the nervous system.Ann. NY Acad. Sci. 55, 330–343.PubMedCrossRefGoogle Scholar
  99. Levi-Montalcini R (1987) The nerve growth factor 35 years later.Science 237, 1154–1162.PubMedCrossRefGoogle Scholar
  100. Levi-Montalcini R and PU Angeletti (1968) Nerve growth factor.Physiol. Rev. 48, 534–569.PubMedGoogle Scholar
  101. Levi-Montalcini R and V Hamburger (1951) Selective growth stimulating effects of mouse sarcomas on the sensory and sympathetic nervous system of chick embryos.J. Exp. Zool. 116, 321–362.PubMedCrossRefGoogle Scholar
  102. Levivier M, S Przedborski, C Bencsics and UJ Kang (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.J. Neurosci. 15, 7810–7820.PubMedGoogle Scholar
  103. Li XM, AV Juorio, J Qi and AA Boulton (1998) L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum. Anin situ hybridization study.Mol. Chem. Neuropathol. 1–3, 149–155.CrossRefGoogle Scholar
  104. Lin LF, DH Doherty, JD Lile, S Bektesh and F Collins (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.Science 260, 1130–1132.PubMedCrossRefGoogle Scholar
  105. Lindner MD, SR Winn, EE Baetge, JP Hammang, FT Gentileet al. (1995) Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms.Exp. Neurol. 132, 62–76.PubMedCrossRefGoogle Scholar
  106. Ling ZD, CW Tong and PM Carvey (1998) Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures.Brain Res. 1–2, 137–145.CrossRefGoogle Scholar
  107. Lopez-Lozano JJ, G Bravo, J Abascal B Brera, ML Pascualet al. (1996) Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease.Transplant. Int. 9, S485-S491.CrossRefGoogle Scholar
  108. Loret C, M Sensenbrenner and G Labourdette (1989) Differential phenotypic expression induced in cultured rat astroblasts by acidic fibroblast growth factor, epidermal, growth factor, and thrombin.J. Biol. Chem. 264, 8319–8327.PubMedGoogle Scholar
  109. Luquin MR, RJ Montoro, J Guillen, L Saldise, R Insaustiet al. (1999) Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen.Neuron 4, 743–750.CrossRefGoogle Scholar
  110. Maisonpierre PC, L Belluscio, B Friedman, RF Alderson, SJ Wiegandet al. (1990a) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression.Neuron 5, 501–509.PubMedCrossRefGoogle Scholar
  111. Maisonpierre PC, L Belluscio, S Squinto, NY Ip, ME Furthet al. (1990b) Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.Science 247, 1446–1451.PubMedCrossRefGoogle Scholar
  112. Mayer E, SB Dunnett, R Pellitteri and JW Fawcett (1993) Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—I. Effectsin vitro.Neuroscience 56, 379–388.PubMedCrossRefGoogle Scholar
  113. Mena MA, JG De Yebenes, A Dwork, N Latov, S Fahn and J Herbert (1987) Neuroblastoma cells as a possible donor for transplantation in animal models of Parkinson's disease.Soc. Neurosci. Abstr. 13, 162.Google Scholar
  114. Mena MA, JG De Yebenes, MJ Casarejos and B Pardo (1988) The effects of growth factors, protein kinase activators and neurotoxins on catecholamine levels, cell size and mitotic rates in human neuroblastoma cells.Neurosci. Lett. Suppl. 28, 90.Google Scholar
  115. Mena MA, JG De Yebenes, A Dwork, S Fahn, N Latovet al. (1989a) Biochemical properties of monamine-rich human neuroblastoma cells.Brain Res. 486, 286–296.PubMedCrossRefGoogle Scholar
  116. Mena MA, JG De Yebenes, R Steinert, A Dwork, R Goodmanet al. (1989b) Transplantes neuronales con celulas diferenciadas procedentes de neuroblastomas humanos en modelos experimentales de enfermedad de Parkinson. In S. Gimenez-Roldan, Ed.,Nuevas estrategias terapeuticas enla enfermedad de Parkinson (Jarpyo, Madrid, Spain), pp 63–79.Google Scholar
  117. Milbrandt J, FJ de Sauvage, TJ Fahrner, RH Baloh, ML Leitneret al. (1998) Persephin, a novel neurotrophic factor related to GDNF and neurturin.Neuron 20, 245–253.PubMedCrossRefGoogle Scholar
  118. Missale C, M Losa, F Boroni, M Giovanelli, A Balsari and PF Spano (1995) Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.Br. J. Cancer 6, 1397–1399.Google Scholar
  119. Mizuta I, M Ohta, K Ohta, M Nishimura, E Mizutaet al. (2000) Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes.Biochem. Biophys. Res. Commun. 3, 751–755.CrossRefGoogle Scholar
  120. Morrison RS, A Sharma, J de Vellis and RA Bradshaw (1986) Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture.Proc. Natl. Acad. Sci. USA 83, 7537–7541.PubMedCrossRefGoogle Scholar
  121. Morrison RS, HI Kornblum, FM Leslie and RA Bradshaw (1987) Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor.Science 238, 72–75.PubMedCrossRefGoogle Scholar
  122. Murer MG, Q Yan and R Raisman-Vozari (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.Prog. Neurobiol. 63, 71–124.PubMedCrossRefGoogle Scholar
  123. Mutoh T, BB Rudkin, S Koizumi and G Guroff (1988) Nerve growth factor, a differentiating agent, and epidermal growth factor, a mitogen, increase the activities of different S6 kinases in PC12 cells.J. Biol. Chem. 31, 15853–15856.Google Scholar
  124. Nanney LB, CM Stoscheck, M Magid and LE King Jr (1986) Altered [125I] epidermal growth factor binding and receptor distribution in psoriasis.J. Invest. Dermatol. 86, 260–265.PubMedCrossRefGoogle Scholar
  125. Nexo E, MD Hollenberg, A Figueroa and RM Pratt (1980) Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development.Proc. Natl. Acad. Sci. USA 77, 2782–2785.PubMedCrossRefGoogle Scholar
  126. Nieto-Sampedro M, ER Lewis, CW Cotman, M Manthorpe, SD Skaperet al. (1982) Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site.Science 217, 860–861.PubMedCrossRefGoogle Scholar
  127. Nieto-Sampedro M, M Manthrope, G Barbin, S Varon and CW Cotman (1983) Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity.J. Neurosci. 3, 2219–2229.PubMedGoogle Scholar
  128. Nieto-Sampedro M, RP Saneto, J de Vellis and CW Cotman (1985) The control of glial populations in brain: changes in astrocyte mitogenic and morphogenic factors in response to injury.Brain Res. 343, 320–328.PubMedCrossRefGoogle Scholar
  129. Ogawa M, T Ishikawa and A Irimajiri (1984) Adrenal chromaffin cells form functional cholinergic synapses in culture.Nature 307, 66–68.PubMedCrossRefGoogle Scholar
  130. Ohta M, I Mizuta, K Ohta, M Nishimura, E Mizutaet al. (2000) Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes.Biochem. Biophys. Res. Commun. 272, 18–22.PubMedCrossRefGoogle Scholar
  131. Olson L, EO Backlund, T Ebendal, R Freedman, B Hambergeret al. (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.Arch. Neurol. 48, 373–381.PubMedGoogle Scholar
  132. Ornitz DM and N Itoh (2001) Fibroblast growth factors.Genome Biol. 2, Reviews S3005.1–3005.12..CrossRefGoogle Scholar
  133. Otto D and K Unsicker (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.J. Neurosci. 10, 1912–1921.PubMedGoogle Scholar
  134. Otto D. and K Unsicker (1994) FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.Glia 11, 47–56.PubMedCrossRefGoogle Scholar
  135. Otto D, M Frotscher and K Unsicker (1989) Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection.J. Neurosci. Res. 22, 83–91.PubMedCrossRefGoogle Scholar
  136. Pearce RK, P Collins, P Jenner, C Emmett and CD Marsden (1996) Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset.Synapse 23, 192–200.PubMedCrossRefGoogle Scholar
  137. Perez-Polo JR (1985) Neuronotrophic factors. In JE Bottenstein and G Sato, Eds.,Cell Cultures in the Neurosciences (Plenum Press, New York), pp 95–123.Google Scholar
  138. Pettmann B, G Labourdette, M Weibel and M Sensenbrenner (1986) The brain fibroblast growth factor (FGF) is localized in neurons.Neurosci. Lett. 68, 175–180.PubMedCrossRefGoogle Scholar
  139. Pezzoli G, S Fahn, A Dwork, DD Truong, JG de Yebeneset al. (1988) Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats.Brain Res. 459, 398–403.PubMedCrossRefGoogle Scholar
  140. Pezzoli G, A Zecchinelli, S Ricciardi, RE Burke, S Fahn, G Scarlato and A Carenzi (1991) Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.Mov. Disord. 6, 281–287.PubMedCrossRefGoogle Scholar
  141. Quirion R, D Araujo NP Nair and JG Chabot (1988) Visualization of growth factor receptor sites in rat forebrain.Synapse 2, 212–218.PubMedCrossRefGoogle Scholar
  142. Ramón y Cajal S (1891)Recuerdos de mi vida: Historia de mi labor científica Alianza Universidad.Google Scholar
  143. Rechler MM and P Nissley (1985) The nature and regulation of the receptors for insulin-like growth factors.Ann. Rev. Physiol. 47, 425–442.CrossRefGoogle Scholar
  144. Recio-Pinto E, MM Rechler and DN Ishii (1986) Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons.J. Neurosci. 6, 1211–1219.PubMedGoogle Scholar
  145. Reubi JC, U Horisberger, W Lang, JW Koper, R Braakman and SW Lamberts (1989) Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.Am. J. Pathol. 134, 337–344.PubMedGoogle Scholar
  146. Rydel RE and LA Greene (1987) Acidic and basic fibroblast growth factors promote stable neurite outgrowth and neuronal differentiation in cultures of PC12 cells.J. Neurosci. 7, 3639–3653.PubMedGoogle Scholar
  147. Sagen J and GD Pappas (1987) Morphological and functional correlates of chromaffin cell transplants in CNS pain modulatory regions.Ann. NY Acad. Sci. 495, 306–333.PubMedCrossRefGoogle Scholar
  148. Sanchez-Pernaute R, D Nagy and KS Bankiewicz (1999) Intrinsic striatal dopaminergic neurons increase in response to trophic factors in parkinsonian monkeys.Am. Soc. Neurosci. 12, 294.Google Scholar
  149. Satoh J and Y Kuroda Y (2001a) Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors.Parkinsonism Relat. Disorders 1, 7–17.CrossRefGoogle Scholar
  150. Satoh JI and Y Kuroda (2001b) Ubiquitin C-terminal hydrolase-L1 (PGP9.5) expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines, neurotrophic factors or heat stress.Neuropathol. Appl. Neurobiol. 2, 95–104CrossRefGoogle Scholar
  151. Schaar DG, BA Sieber, CF Dreyfus and IB Black (1993) Regional and cell-specific expression of GDNF in rat brain.Exp. Neurol. 124, 368–371.PubMedCrossRefGoogle Scholar
  152. Schechter R, L Holtzclaw, F Sadiq, A Kahn and S Devaskar (1988) Insulin synthesis by isolated rabbit neurons.Endocrinology 123, 505–513.PubMedGoogle Scholar
  153. Schubert D and C Whitlock (1977) Alteration of cellular adhesion by nerve growth factor.Proc. Natl. Acad. Sci. USA 74, 4055–4058.PubMedCrossRefGoogle Scholar
  154. Shults CW, T Kimber and D Martin (1996), Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine.Neuroreport 7, 627–631.PubMedCrossRefGoogle Scholar
  155. Siegel GJ and NB Chauhan (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain.Brain Res. Brain Res. Rev. 2–3, 199–227.CrossRefGoogle Scholar
  156. Sievers J, B Hausmann, K Unsicker and M Berry (1987) Fibroblast growth factors promote the survival of adult rat retinal ganglion cells after transection of the optic nerve.Neurosci. Lett. 76, 157–162.PubMedCrossRefGoogle Scholar
  157. Springer JE, JL Seeburger, J He, A Gabrea, EP Blankenhorn and LW Bergman (1995) cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle.Exp. Neurol. 131, 47–52.PubMedCrossRefGoogle Scholar
  158. Stemple DL, NK Mahanthappa and DJ Anderson (1988) Basic FGF induces neuronal differentiation, cell division, and NGF dependence in chromaffin cells: a sequence of events in sympathetic development.Neuron 1 517–525.PubMedCrossRefGoogle Scholar
  159. Stromberg I, L Bjorklund, M Johansson, A Tomac, F Collinset al. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neuronsin vivo.Exp. Neurol. 124, 401–412.PubMedCrossRefGoogle Scholar
  160. Takayama H, J Ray, HK Raymon, A Baird, J Hogget al. (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease.Nature Med. 1, 53–58.PubMedCrossRefGoogle Scholar
  161. Tello JF (1911) La influencia del neurotropismo en la regeneración de los centros nerviosos.Trab. Lab Invest. Biol. Univ. de Madrid 9, 123–159.Google Scholar
  162. Theofilopoulos S, J Goggi, SS Riaz, E Jauniaux, GM Stern and HF Bradford (2001) Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor.Brain Res. Dev. Brain Res. 127, 111–122.PubMedCrossRefGoogle Scholar
  163. Thoenen H (1991) The changing scene, of neurotrophic factors.Trends Neurosci. 14, 165–170.PubMedCrossRefGoogle Scholar
  164. Tischler AS, YC Lee, VW Slayton and SR Bloom (1982) Content and release of neurotensin in PC12 pheochromocytoma cell cultures: modulation by dexamethasone and nerve growth factor.Regul. Pept. 3, 415–421.PubMedCrossRefGoogle Scholar
  165. Togari A, G Dickens, H Kuzuya and G Guroff (1985) The effect of fibroblast growth factor on PC12 cells.J. Neurosci. 5, 307–316.PubMedGoogle Scholar
  166. Tomac A, J Widenfalk, LF Lin, T Kohno, T Ebendalet al. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.Proc. Natl. Acad. Sci. USA 92, 8274–8278.PubMedCrossRefGoogle Scholar
  167. Tooyama I, D Walker, T Yamada, K Hanai, H Kimuraet al. (1992) High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain.Brain Res. 593, 274–280.PubMedCrossRefGoogle Scholar
  168. Tooyama I, T Kawamata, D Walker, T Yamada, K Hanaiet al. (1993) Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease.Neurology 43, 372–376.PubMedGoogle Scholar
  169. Tooyama I, EG McGeer, T Kawamata, H Kimura and PL McGeer (1994) Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease.Brain Res. 656, 165–168.PubMedCrossRefGoogle Scholar
  170. Traynor AE, D Schubert and WR Allen (1982) Alterations of lipid metabolism in response to nerve growth factor.J. Neurochem. 39, 1677–1683.PubMedCrossRefGoogle Scholar
  171. Treanor JJ, L Goodman, F de Sauvage, DM Stone, KT Poulsen,et al. (1996) Characterization of a multicomponent receptor for GDNF.Nature 382, 80–83.PubMedCrossRefGoogle Scholar
  172. Trupp M, M Ryden, H Jornvall, H Funakoshi, T Timmusket al. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons.J. Cell Biol. 130, 137–148.PubMedCrossRefGoogle Scholar
  173. Tsukahara T, M Takeda, S Shimohama, O Ohara and N Hashimoto (1995) Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.Neurosurgery 37, 733–739; discussion 739-741.PubMedCrossRefGoogle Scholar
  174. Unsicker K, B Krisch, U Otten and H Thoenen (1978) Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids.Proc. Natl. Acad. Sci. USA 75, 3498–3502.PubMedCrossRefGoogle Scholar
  175. Unsicker K, H Reichert-Preibsch, R Schmidt, B Pettmann, G Labourdette and M Sensenbrenner (1987) Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons.Proc. Natl. Acad. Sci. USA 84, 5459–5463.PubMedCrossRefGoogle Scholar
  176. Unsicker K, H Reichert-Preibsch and K Wewetzer (1992) Stimulation of neuron survival by basic FGF and CNTF is a direct effect and not mediated by non-neuronal cells: evidence from single cell cultures.Brain Res. Dev. Brain Res. 65, 285–288.PubMedCrossRefGoogle Scholar
  177. Ventrella LL (1993) Effect of intracerebroventricular infusion of epidermal growth factor in rats hemitransected in the nigro-striatal pathway.J. Neurosurg. Sci. 37, 1–8.PubMedGoogle Scholar
  178. Vinores SA, PJ Marangos, AM Parma and G Guroff (1981) Increased levels of neuron-specific enolase in PC12 pheochromocytoma cells as a result of nerve growth factor treatment.J. Neurochem. 37, 597–600.PubMedCrossRefGoogle Scholar
  179. Volpe BT, J Wildmann and CA Altar (1998) Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions.Neuroscience 83, 741–748.PubMedCrossRefGoogle Scholar
  180. Walicke PA and A Baird (1988) Neurotrophic effects of basic and acidic fibroblast growth factors are not mediated through glial cells.Brain Res. 468, 71–79.PubMedGoogle Scholar
  181. Walicke P, WM Cowan, N Ueno, A Baird and R Guillemin (1986) Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.Proc. Natl. Acad. Sci. USA 83, 3012–3016.PubMedCrossRefGoogle Scholar
  182. Walicke PA, JJ Feige and A Baird (1989) Characterization of the neuronal receptor for basic fibroblast growth factor and comparison to receptors on mesenchymal cells.J. Biol. Chem. 264, 4120–4126.PubMedGoogle Scholar
  183. Walker DG, K Terai, A Matsuo, TG Beach, EG McGeer and PL McGeer (1998) Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases.Brain Res. 794, 181–187.PubMedCrossRefGoogle Scholar
  184. Wang J, KS Bankiewicz, RJ Plunkett and EH Oldfield (1994) Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.J. Neurosurg. 80, 484–490.PubMedGoogle Scholar
  185. Weinstein IB, LS Lee, PB Fisher, A Mufson and H Yamasaki (1979) Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes.J. Supramol. Struct. 12, 195–208.PubMedCrossRefGoogle Scholar
  186. Westermark B (1977) Local starvation for epidermal growth factor cannot explain density-dependent inhibition of normal human glial cells.Proc. Natl. Acad. Sci. USA 74, 1619–1621.PubMedCrossRefGoogle Scholar
  187. Yoshimoto Y, Q Lin, TJ Collier, DM Frim, XO Breakefieldet al. (1995) Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease.Brain Res. 691, 25–36.PubMedCrossRefGoogle Scholar
  188. Young WS 3rd (1986) Periventricular hypothalamic cells in the rat brain contain insulin mRNA.Neuropeptides 8, 93–97.PubMedCrossRefGoogle Scholar
  189. Yurek DM and JR Sladek Jr (1990) Dopamine cell replacement: Parkinson's disease.Ann. Rev. Neurosci. 13, 415–440.PubMedCrossRefGoogle Scholar
  190. Yurek DM, W Lu, S Hipkens and SJ Wiegand (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons.Exp. Neurol. 137, 105–118.PubMedCrossRefGoogle Scholar
  191. Zhang W, WH Lee and LC Triarhou (1996) Grafted cerebellar cells in a mouse model of hereditary ataxia express IGF-I system genes and partially restore behavioral function.Nature Med. 2, 65–71.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2003

Authors and Affiliations

  • Justo Garcia De Yébenes
    • 1
  • Marina Sánchez
    • 1
  • Maria Angeles Mena
    • 2
  1. 1.Servicio de NeurologíaFundación Jiménez DíazMadridSpain
  2. 2.Department of ResearchHospital Ramón y CajalMadridSpain

Personalised recommendations